|
| 36529953 | Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animals. | | 2023 |
| 36270297 | Introduction to the Theme "Development of New Drugs: Moving from the Bench to Bedside and Improved Patient Care". | Annual Review of Pharmacology and Toxicology | 2023 |
| 37816308 | Introduction to the Theme "Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug Treatment". | | 2023 |
| 37615850 | Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | Adv Ther | 2023 |
| 37092682 | BJP recommendations for publishing research on tobacco smoke and environmental tobacco smoke exposure. | | 2023 |
| 36876456 | Considering and reporting sex as an experimental variable II: An update on progress in the British Journal of Pharmacology. | | 2023 |
| 37120813 | Mast cell tolerance in the skin microenvironment to commensal bacteria is controlled by fibroblasts. | | 2023 |
| 36602887 | GPCR Signaling Measurement and Drug Profiling with an Automated Live-Cell Microscopy System. | | 2023 |
| 34606327 | Introduction to the Theme "New Insights, Strategies, and Therapeutics for Common Diseases". | Annual Review of Pharmacology and Toxicology | 2022 |
| 35387344 | PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells. | Frontiers in Pharmacology | 2022 |
| 35673806 | Planning experiments: Updated guidance on experimental design and analysis and their reporting III. | British Journal of Pharmacology | 2022 |
| 34795026 | Inhaled 2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome? | Pharmacological Reviews | 2021 |
| 33631357 | RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. | Contemp Clin Trials | 2021 |
| 34328225 | Editorial policy regarding the citation of preprints in the British Journal of Pharmacology (BJP). | British Journal of Pharmacology | 2021 |
| 34085259 | Detection of GPCR mRNA Expression in Primary Cells Via qPCR, Microarrays, and RNA-Sequencing. | Methods in Molecular Biology | 2021 |
| 33124941 | Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. | Physiological Reviews | 2021 |
| 33411582 | Introduction to the Theme "Old and New Toxicology: Interfaces with Pharmacology". | Annual Review of Pharmacology and Toxicology | 2021 |
| 32662875 | ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. | British Journal of Pharmacology | 2020 |
| 31914892 | Introduction to the Theme "Ion Channels and Neuropharmacology: From the Past to the Future". | Annual Review of Pharmacology and Toxicology | 2020 |
| 32372523 | Cyclic AMP in dendritic cells: A novel potential target for disease-modifying agents in asthma and other allergic disorders. | British Journal of Pharmacology | 2020 |
| 32320478 | Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence. | Clinical Pharmacology and Therapeutics | 2020 |
| 31960631 | Transcriptomic profiles reveal differences between the right and left ventricle in normoxia and hypoxia. | Physiological Reports | 2020 |
| 32060895 | GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets. | British Journal of Pharmacology | 2020 |
| 32116003 | Proton-sensing G protein-coupled receptors: detectors of tumor acidosis and candidate drug targets. | Future Medicinal Chemistry | 2020 |
| 32298474 | A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research. | British Journal of Pharmacology | 2020 |
| 32337710 | Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension. | British Journal of Pharmacology | 2020 |
| 32333398 | A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. | British Journal of Pharmacology | 2020 |
| 33496632 | Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients. | American Journal of Physiology - Lung Cellular and Molecular Physiology | 2020 |
| 33203679 | Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. | Proceedings of the National Academy of Sciences of the United States of America | 2020 |
| 32639031 | Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19? | British Journal of Pharmacology | 2020 |
| 33108103 | RAAS Inhibitors and Risk of Covid-19. | New England Journal of Medicine | 2020 |
| 31078319 | GPCRomics: An Approach to Discover GPCR Drug Targets. | Trends in Pharmacological Sciences | 2019 |
| 31646252 | Detection and Quantification of GPCR mRNA: An Assessment and Implications of Data from High-Content Methods. | ACS Omega | 2019 |
| 31950490 | The BJP expects authors to share data. | British Journal of Pharmacology | 2019 |
| 31765370 | GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors. | PLoS Biol | 2019 |
| 30625286 | Introduction to the Theme "New Therapeutic Targets". | Annual Review of Pharmacology and Toxicology | 2019 |
| 30758990 | Prostaglandin E<sub>2</sub> inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca<sup>2+</sup> signaling. | Am J Physiol Lung Cell Mol Physiol | 2019 |
| 30696114 | GPR68: An Emerging Drug Target in Cancer. | International Journal of Molecular Sciences | 2019 |
| 29298813 | G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? | Molecular Pharmacology | 2018 |
| 29058990 | Introduction to the Theme "New Approaches for Studying Drug and Toxicant Action: Applications to Drug Discovery and Development". | Annual Review of Pharmacology and Toxicology | 2018 |
| 29872392 | GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets. | Front Pharmacol | 2018 |
| 29350411 | Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. | British Journal of Pharmacology | 2018 |
| 29092903 | GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells. | FASEB J | 2018 |
| 29520785 | Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. | British Journal of Pharmacology | 2018 |
| 28122734 | Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology. | American Journal of Physiology - Cell Physiology | 2017 |
| 28801996 | Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts. | British Journal of Pharmacology | 2017 |
| 27732830 | Introduction to the Theme "New Methods and Novel Therapeutic Approaches in Pharmacology and Toxicology". | Annual Review of Pharmacology and Toxicology | 2017 |
| 26675706 | Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation. | FASEB J | 2016 |
| 26955961 | The Gq signalling pathway inhibits brown and beige adipose tissue. | Nature Communications | 2016 |
| 26984025 | The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman. | Molecular Pharmacology | 2016 |